Literature DB >> 15970950

PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism.

Christine Klein1, Ana Djarmati, Katja Hedrich, Nora Schäfer, Cesa Scaglione, Roberta Marchese, Norman Kock, Birgitt Schüle, Anja Hiller, Thora Lohnau, Susen Winkler, Karin Wiegers, Robert Hering, Peter Bauer, Olaf Riess, Giovanni Abbruzzese, Paolo Martinelli, Peter P Pramstaller.   

Abstract

Recessively inherited early-onset parkinsonism (EOP) has been associated with mutations in the Parkin, DJ-1, and PINK1 genes. We studied the prevalence of mutations in all three genes in 65 Italian patients (mean age of onset: 43.2+/-5.4 years, 62 sporadic, three familial), selected by age at onset equal or younger than 51 years. Clinical features were compatible with idiopathic Parkinson's disease in all cases. To detect small sequence alterations in Parkin, DJ-1, and PINK1, we performed a conventional mutational analysis (SSCP/dHPLC/sequencing) of all coding exons of these genes. To test for the presence of exon rearrangements in PINK1, we established a new quantitative duplex PCR assay. Gene dosage alterations in Parkin and DJ-1 were excluded using previously reported protocols. Five patients (8%; one woman/four men; mean age at onset: 38.2+/-9.7 (range 25-49) years) carried mutations in one of the genes studied: three cases had novel PINK1 mutations, one of which occurred twice (homozygous c.1602_1603insCAA; heterozygous c.1602_1603insCAA; heterozygous c.836G>A), and two patients had known Parkin mutations (heterozygous c.734A>T and c.924C>T; heterozygous c.924C>T). Family history was negative for all mutation carriers, but one with a history of tremor. Additionally, we detected one novel polymorphism (c.344A>T) and four novel PINK1 changes of unknown pathogenic significance (-21G/A; IVS1+97A/G; IVS3+38_40delTTT; c.852C>T), but no exon rearrangements. No mutations were found in the DJ-1 gene. The number of mutation carriers in both the Parkin and the PINK1 gene in our cohort is low but comparable, suggesting that PINK1 has to be considered in EOP.

Entities:  

Mesh:

Year:  2005        PMID: 15970950     DOI: 10.1038/sj.ejhg.5201455

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  39 in total

Review 1.  Genetics of Parkinson's disease.

Authors:  Christine Klein; Ana Westenberger
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  PINK1 mutation heterozygosity and the risk of Parkinson's disease.

Authors:  M Toft; R Myhre; L Pielsticker; L R White; J O Aasly; M J Farrer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

Review 3.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

4.  Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis.

Authors:  Anne Grünewald; Guido J Breedveld; Katja Lohmann-Hedrich; Christan F Rohé; Inke R König; Johann Hagenah; Nicola Vanacore; Giuseppe Meco; Angelo Antonini; Stefano Goldwurm; Suzanne Lesage; Alexandra Dürr; Ferdinand Binkofski; Hartwig Siebner; Alexander Münchau; Alexis Brice; Ben A Oostra; Christine Klein; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2007-01-12       Impact factor: 2.660

5.  Molecular diversity of combined and complex dystonia: insights from diagnostic exome sequencing.

Authors:  Michael Zech; Robert Jech; Matias Wagner; Tobias Mantel; Sylvia Boesch; Michael Nocker; Angela Jochim; Riccardo Berutti; Petra Havránková; Anna Fečíková; David Kemlink; Jan Roth; Tim M Strom; Werner Poewe; Evžen Růžička; Bernhard Haslinger; Juliane Winkelmann
Journal:  Neurogenetics       Date:  2017-08-28       Impact factor: 2.660

Review 6.  The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.

Authors:  Abdelmagid M Elmatboly; Ahmed M Sherif; Dalia A Deeb; Amira Benmelouka; May N Bin-Jumah; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-19       Impact factor: 4.223

7.  Analysis of exon dosage using MLPA in South African Parkinson's disease patients.

Authors:  Rowena J Keyser; Debbie Lombard; Rene Veikondis; Jonathan Carr; Soraya Bardien
Journal:  Neurogenetics       Date:  2009-12-15       Impact factor: 2.660

8.  Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.

Authors:  J Brooks; J Ding; J Simon-Sanchez; C Paisan-Ruiz; A B Singleton; S W Scholz
Journal:  J Med Genet       Date:  2009-04-06       Impact factor: 6.318

9.  Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.

Authors:  Jung Mi Choi; Myoung Soo Woo; Hyeo-Il Ma; Suk Yun Kang; Young-Hee Sung; Seok Woo Yong; Sun Ju Chung; Joong-Seok Kim; Hae-won Shin; Chul Hyoung Lyoo; Phil Hyu Lee; Jong Sam Baik; Sang-Jin Kim; Mee Young Park; Young Ho Sohn; Jin-Ho Kim; Jae Woo Kim; Myung Sik Lee; Myoung Chong Lee; Dong-Hyun Kim; Yun Joong Kim
Journal:  Neurogenetics       Date:  2008-08-15       Impact factor: 2.660

Review 10.  Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.

Authors:  Dena G Hernandez; Xylena Reed; Andrew B Singleton
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.